The results were stunning. So too was the nationality of the company behind them. Akeso, a biotech firm, is Chinese.
1h
Hosted on MSNModerna: A Generational Opportunity for Investors in 2025As bad as it may look on the charts, Moderna’s (NASDAQ: MRNA) post-COVID let-down and market reset are over. The company ...
Japan's exports rose for a fourth consecutive month in January led by auto shipments to the United States, but if U.S.
MIND Technology's effective strategies have led to increased margins and profitability. Click here to read why MIND stock is ...
16h
Investor's Business Daily on MSNWhy Medtronic Just Undercut Its Buy Zone With A 7% DropMedtronic stock skidded Tuesday after the medtech giant missed sales expectations, though profit came in well ahead of forecasts.
Taylor Swift is getting to the top.The popstar has officially made history, surpassing Madonna as the female artist with the ...
Rivian is already selling its product to customers, has new products in the pipeline, and is on its way to gross ...
Restaurant Brands posted strong Q4 results, driven by Tim Hortons' success in Canada and recovery at Burger King. Learn more ...
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...
A trio of high-octane income stocks -- sporting an average yield of 6.65% -- can fatten investors' pocketbooks in 2025 (and ...
At this time, I'd like to welcome everyone to the Biogen fourth-quarter and full-year 2024 earnings call and business update. (Operator Instructions) Today's conference is being recorded. Thank you. I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results